Evaluation of Nasal Mucociliary Clearance in Recently Diagnosed Covid-19 Patients Before Treatment

Authors : Ahmet Köder, Saffet Kiliçaslan, Abdullah Belada, Arif Doğan Habiloğlu, Özlem Ataoğlu, Mehmet Ali Sungur, Dursun Atik

Pages : 308-312

Doi:10.18521/ktd.1217744

View : 132 | Download : 277

Publication Date : 2023-10-20

Article Type : Research Paper

Abstract :Objective: Our study aims to evaluate the nasal mucociliary clearance (NMC) in Covid-19 patients who have been recently diagnosed and not been treated yet and investigate how Covid-19 affects NMC. Methods: A total of 120 participants, who applied to Düzce Atatürk State Hospital between September and November 2020, were included in our study. 60 of them were the participants, diagnosed with Covid-19. And 60 of them were the control group. The age range was 18 to 66. 60 participants, diagnosed with Covid-19 and not yet treated, were included in our study. Those with taste disorders were excluded from the study. The control group consisted of 60 healthy volunteers. NMC was evaluated using a saccharin test. The results were compared in the Statistical Package for Social Sciences (SPSS). Results: The study group, which consisted of 60 Covid-19 participants of whom treatment was not yet started, and the 60-participant healthy control group were evaluated in our study. The average age of the study group was 40,72±12,96 and 39,16 in the control group. The average NMC was 15,95±3,37 in the study group, and 8,38±1,03 in the control group. When evaluated statistically, it was found higher in the study group (p<0,001). Conclusions: NMC acts as a barrier for inhaled foreign bodies. It is a non-specific protection system against airborne pathogens. Consequently, NMC extends in Covid- 19 patients.
Keywords : Kovid 19, Nazal Mukosiliyer Klirens, Koku Bozuklukları

ORIGINAL ARTICLE URL